更新 2024.3.26
このエントリーをはてなブックマークに追加

MANUAL

TOP PAGE

LINK

Kids-Hero Research Institute.

<< 4558
中京医薬

LIST

4563
アンジェス
>>

ZERIA PHARMACEUTICAL CO.,LTD. (4559:TYO-JP)

4559

       
Company INFORMATION
  Trading Symbol 4559
  Company Name ZERIA PHARMACEUTICAL CO.,LTD.
  Website http://www.zeria.co.jp/
  Incorporated 1955年12月22日
  Employees 847人
  Description  
  The Zeria Pharmaceutical Group consists of the company and 17 subsidiaries (Zeria Healthway, Zebis, Iona International, Tillotts Pharma AG, ZPD A/S, etc.) and is engaged in the prescription drug business, consumer healthcare business, and other businesses. The Ethical Drug Business is engaged in the manufacture, purchase, and sale of ethical drugs. In the Consumer Healthcare Business, we manufacture, purchase, and sell self-medication-related over-the-counter (OTC) drugs and health food products, purchase, sell, and import/export raw materials for health food products, mainly through OEM (Original Equipment Manufacturer) channels other than pharmacies and distributors, and manufacture and sell cosmetics, including quasi-drugs. Other businesses include the insurance agency and real estate businesses, the purchase and sale of promotional materials, and various maintenance services.
Highly correlated Stock
  5262 日本ヒューム(株)   9882 (株)イエローハット   4732 (株)ユー・エス・エス   9678 (株)カナモト   2267 (株)ヤクルト本社   6849 日本光電工業(株)   9994 (株)やまや   3302 帝国繊維(株)   6340 澁谷工業(株)   9769 (株)学究社   5933 アルインコ(株)   7917 藤森工業(株)   4212 積水樹脂(株)   2502 アサヒグループホールディングス(株)   1949 住友電設(株)   1835 東鉄工業(株)  
Other Websites
  KHRI(japanese site)   market.ft.com   GOOGLE FINANCE   STOCKOPEDIA   MARKET WATCH   BARRON'S   CNBC   REUTERS   WSJ   TRADING ECONOMICS  

URL of ZERIA PHARMACEUTICAL CO.,LTD. (4559:TYO-JP)
http://kids-hero.main.jp/japan_market/code4559.html

KHRI's Artificial intelligence evaluates evaluation results and evaluates the accuracy of individual data predictions. KHRI's Artificial intelligence analyzes economic movements using a model described in mathematics and performs extrapolation calculations toward the future.

To the TOP


[SITE BROWSING CONDITIONS] IMPORTANT!
Browsing of this site requires your understanding and consent to all of the contents described below. If you do not agree to the following items, you are prohibited from browsing this site. Please stop browsing immediately.
This site is intended to contribute to research activities in the field of information technology and to stabilize the economy through such activities, and is NOT INTENDED to sell or solicit financial products. Permission is granted to view this site for research activities only. Viewing this site is at the visitor's own risk. The Administrator of this web site is not responsible for any damages or problems caused by your use of the information provided by this site for research activities. The Administrator of this web site reserves the right to update, change, delete, or discontinue publication of information on this site without prior notice. Although every effort has been made to ensure the accuracy of the information posted on this site, incorrect information may be posted against the administrator's intention due to malfunction of equipment or artificial alteration by a third party. Please use the data and information for your research activities at your own discretion. The data and information on this site is intended to be used for research activities. And the data and information is caluculated automatically generated by KHRI original mathematical algorithm. Therefore, we do not intentionally manipulate information on specific stocks. Due to the convenience of processing, the stock prices posted on this site are not the latest stock prices, and there is a time lag. Please check the update date of each page.
All copyrights to the information on this site (including logos, images, and text) belong to the Kids-Hero Research Institute and information providers. Any diversion, duplication, sale, etc. of the information posted on this site is strictly prohibited.




Copyright (c) Kids-Hero Research Institute. All Rights Reserved.